 |
|
|
 |
FDA approves Erbitux for colorectal cancer
Yesterday, FDA approved Erbitux (cetuximab) to treat patients with advanced colorectal
cancer that has spread to other parts of the body. Erbitux is the first monoclonal
antibody approved to treat this type of cancer and is indicated as a combination
treatment to be given intravenously with irinotecan, another drug approved to
fight colorectal cancer, or alone if patients cannot tolerate irinotecan. more
|
|
Information for patients and practitioners: Questions and answers on Erbitux (cetuximab)
Erbitux is a monoclonal antibody that targets a protein called the epidermal
growth factor receptor (EGFR). EGFR is found on the surface of some cells, and plays a role in regulating cell growth. Erbitux is believed to interfere with the growth of cancer cells by binding to EGFR so that the normal (natural) epidermal growth factors cannot
bind and stimulate the cells to grow.
more
|
|
Prescribing information: Erbitux (cetuximab)
Erbitux is a new type of cancer drug used to treat cancer of the colon or rectum that has spread to other parts of the body. Erbitux is given with irinotecan, another anti-cancer medicine, or alone in patients who cannot tolerate irinotecan.
more
|
|
|
|
Information for practitioners: Treatment of colon cancer
Cancer of the colon is a highly treatable and often curable disease when localized to the bowel. It is the second most frequently diagnosed malignancy in the United States as well as the second most common cause of cancer death. more
|
|
Diabetes doubles risk of liver disease and liver cancer
In the largest study of its kind, researchers have shown that diabetes can cause chronic liver disease and cancer of the liver. more
|
|
Diabetes patients skip medications to save money
In a recent nationwide survey, University of Michigan Health System researchers found diabetes patients' prescription drugs costs – which frequently mounted above $100 a month – created a financial burden that led to increasing credit card debt, borrowing money from family or friends and even cutting back on basic needs such as food or heat.
more
|
|
Hormone released by bone marrow cells may hasten recovery from brain injury
Bone marrow stromal cells release a blood vessel-dilating hormone found in the brain -- a finding that suggests the hormone may be tapped to help with recovery from stroke or other neurological injuries disrupting blood flow to the central nervous system, researchers at the University of South Florida and James A. Haley Veterans' Hospital report for the first time. more
|
|
|
